Trade Moderna Inc ^MRNA

Moderna (MRNA) Plans $2B of Zero-Coupon Convertible Debt. Is the Capped Call Enough to Control Dilution?

FDA Approves 3 New COVID-19 Vaccines

Jim Cramer Says Hold on to Moderna (MRNA) After Phase 3 Cancer Trial

Moderna (MRNA) & Merck (MRK): What's Happening With These Two Stocks? - Insider Monkey

Updated COVID shots are approved. Getting one may not be simple

Moderna (MRNA), Merck (MRK) Cancer Vaccine Wins in Late-Stage Trial

Moderna matches record 175% capped-call strike on US$2.6bn CB | IFR

FDA Approves Seasonal Covid-19 Vaccines From Moderna, Pfizer, BioNTech, Novavax - Update | Morningstar

Moderna Stock Falls 6% On Announcement Of $2.6 Bln Private Offering Of Convertible Senior Notes

BioNTech Tumbles 8% as Colorectal Cancer Vaccine Trial Fails, Moderna Drops 6%, Pfizer Holds Flat

FDA approves updated COVID vaccines targeting XFG 'Stratus' variant

简报聊天：多莉·帕顿如何在科学领域留下自己的印记

Moderna (NASDAQ:MRNA) Sees Strong Trading Volume Following Analyst Upgrade

BioNTech drops 10% on mRNA trial failure, highlighting Moderna contrast

Moderna (MRNA) Stock Earns Another Upgrade on Intismeran Success

Moderna, Inc. (MRNA) Stock: Slide as Company Upsizes Debt Offering to $2.6 Billion

Moderna (MRNA) Stock Drops 4.6% Despite Groundbreaking Cancer Vaccine Breakthrough

Moderna (NASDAQ:MRNA) Sees Strong Trading Volume on Analyst Upgrade - Stock Observer

Success after a century of failures: Inside Moderna and Merck's cancer vaccine breakthrough - Yahoo News Singapore

Best Healthcare Stocks To Follow Now - August 28th - Daily Political

OMERS ADMINISTRATION Corp Purchases New Stake in Moderna, Inc. $MRNA

Best Biotech Stocks To Research - August 28th - Daily Political

Promising Healthcare Stocks To Follow Today - August 25th - Stock Observer

US FDA approves new Covid-19 vaccines ahead of 2026-27 season; here's who can get them

FDA approves updated Covid-19 vaccines

Tempus AI (TEM) Jumped on Moderna's Melanoma Win. Did its $1.5B Personalis Acquisition Just Get Validated?

FDA Approves Seasonal Covid-19 Vaccines From Moderna, Pfizer, BioNTech | Morningstar

BioNTech (BNTX) Rallied on Moderna's Win. Does a Competitor's Success Validate its Oncology Pipeline?

Cathie Wood sells $4 million of surging AI stock

Biotech Stocks To Watch Today - August 27th - Markets Daily

Moderna (NASDAQ:MRNA) Shares Gap Down - Here's What Happened - Markets Daily

Moderna (MRNA) Stock: Slips After Announcing $2 Billion Debt Plan to Fund Growth Strategy

Top Healthcare Stocks To Watch Now - August 27th - Stock Observer

Moderna Capitalizes on Stock Jump With $2 Billion Offering (1)

Moderna raises $2 billion in convertible notes for cancer vaccine

Moderna (NASDAQ:MRNA) Shares Gap Down - Here's What Happened - Stock Observer

Parallax Volatility Advisers L.P. Invests $2.76 Million in Moderna, Inc. $MRNA

Promising Value Stocks To Consider - August 24th - Markets Daily

11,211 Shares in Moderna, Inc. $MRNA Bought by Quantbot Technologies LP

3,753 Shares in Moderna, Inc. $MRNA Acquired by Evolve Private Wealth LLC - Markets Daily

12,894 Shares in Moderna, Inc. $MRNA Bought by Ausdal Financial Partners Inc.

EFG International AG Makes New Investment in Moderna, Inc. $MRNA - Daily Political

3,753 Shares in Moderna, Inc. $MRNA Purchased by Evolve Private Wealth LLC - Stock Observer

Top Healthcare Stocks To Keep An Eye On - August 26th - Markets Daily

Dolly Parton once gave $1 million to help develop the Moderna COVID vaccine at Vanderbilt: 'I'm kind of addicted to the feeling of giving'

Moderna Drops 7% Despite a Fresh Wolfe Research Upgrade, BioNTech Slips

Moderna Stock Carries A Market Value Its Revenue Does Not Support

$7+ Billion mRNA Vaccines Market Outlook, 2035: Opportunities, Strategies, Challenges

Moderna's cancer vaccine cuts melanoma recurrence risk in early trial: What we know - BusinessToday

Northwestern Mutual Wealth Management Co. Buys Shares of 14,469 Moderna, Inc. $MRNA

4,641 Shares in Moderna, Inc. $MRNA Bought by EP Wealth Advisors LLC - Markets Daily

Can Wolfe's upgrade push Moderna stock higher?

EP Wealth Advisors LLC Takes $325,000 Position in Moderna, Inc. $MRNA - Stock Observer

AI-Powered Moderna Stuns Markets with Interim Report: MistRx Leads China's Booming AI4S Innovation Track

Vise Technologies Inc. Takes $381,000 Position in Moderna, Inc. $MRNA - Daily Political

Moderna (MRNA) CEO Warns China Is Catching Up In MRNA Technology

China rushes to develop Moderna-style cancer vaccines amid market frenzy

Health Care Up as Biotech Momentum Persists - Health Care Roundup | Morningstar

Wolfe Research Just Upgraded Moderna Stock. Here's Why.

Merck Just Gained 19% in a Month. What Would It Take to Get MRK Stock Up to $200?

Trump's US$65,000 Moderna trade is untouchable by law - a Canadian minister would need a blind trust for that

Moderna Stock Soars on Cancer Vaccine Breakthrough

Explainer-How the Merck/Moderna cancer vaccine works and possible barriers to wide use

Moderna (NASDAQ:MRNA) Trading Up 11% - Should You Buy?

3 Reasons AI Stocks are Primed for a Rebound

The Next AI Bottleneck Isn't Chips. It's Biology

Moderna Rallies 11%, BioNTech Ticks Up: Is the mRNA Trade Down to One Name?

Merck (MRK) Surges on a Melanoma Win. Can Intismeran Extend Keytruda's Growth Runway? - Insider Monkey

Here Are Tuesday's Top Wall Street Analyst Research Calls: Advanced Micro Devices, Dynatrace, Five Below, Fortune Brands, Klarna Group, Jersey Mike's Subs, Moderna, Sherwin-Williams, and More

Cancer Vaccine Breakthrough Lifts 5 Biotech Names. Here's Who's Best Positioned.

Moderna Shares Rebound After Pullback Following Cancer Vaccine Rally

Wolfe Research Issues Positive Forecast for Merck & Co., Inc. (NYSE:MRK) Stock Price - Daily Political

Commerce Bank Purchases Shares of 55,243 Moderna, Inc. $MRNA

Brandywine Managers LLC Purchases Shares of 9,510 Moderna, Inc. $MRNA

MRNA: Future Upside Will Hinge On Melanoma Cancer Vaccine Breakthrough

Health Care Flat on Retreat From Tech - Health Care Roundup | Morningstar

Moderna stock jumps amid announcement of melanoma vaccine treatment | Fox Business Video

Moderna Stock Had A Readout Waiting In Plain Sight

Marvell, Micron, SpaceX, XPeng, Tesla, Moderna, and More Stocks That Explain Today's Market

Moderna (NASDAQ:MRNA) Shares Down 8.2% - Should You Sell?

Moderna Sinks 7% as Traders Book Profits on a 392% Year-to-Date Surge; BioNTech Drops 4%, Merck Slips

Biotech stocks are breaking out. How Josh Brown is trading them

BioNTech Moved Higher as the Broader Biotech Sector Hit a Post-Pandemic Peak, but BNTX Stock Needs Stronger Fundamentals to Keep Climbing

A cancer vaccine years in the making just proved itself

Promising Value Stocks To Consider - August 24th - Daily Political

Moderna CEO Stéphane Bancel details landmark cancer vaccine breakthrough | Fox Business Video

Moderna (MRNA) Stock Skyrockets 177% on Melanoma Vaccine Breakthrough - Can It Last?

1 Large-Cap Stock with Impressive Fundamentals and 2 We Turn Down

Theleme Partners LLP Takes $564.27 Million Position in Moderna, Inc. $MRNA

Moderna (NASDAQ:MRNA) Price Target Raised to $77.00

Moderna and Merck Show Different Paths From Breakthrough to Value

Trending Stock CFDs: Uber CFD, Palantir CFD, Moderna CFD

US Economy on Stagflation Watch: Apollo Global Management's Outlook

AI Podcast: Fresh Insights on Fed Rate Cut Timing - News in a New Way

Trending stocks to watch: AMD, GOOG, NVDA, AMZN, MSFT

Morning Note: US Retail Dip, Moderna Struggles & Japan’s Inflation Surge

VOO etf news: The Vanguard S&P 500 ETF is down 0.13%

Week Ahead: Investors Focus on U.S. Inflation Data

Trump's Sudden Russia Policy Shift: Rubio's Influence and Implications

Global Market Review: Gold Volatility and Tech Stock Surge Amidst Economic Uncertainty

September CPI Data: Inflation Hurdles, Tariff Impacts, and Fed Rate Cut Expectations

Navigating the AI Boom: Strategies for Investors Amid Nvidia's Valuation Surge

Fund Managers Cautious in Q4: AI, Inflation, and Monetary Policy in Focus

US Government Shutdown Threatens October Inflation Data Release

US-EU Relations: Russia Sanctions Unite Despite Trade Tensions

BOJ Warns of Japan Stock Market Overheating, U.S. Trade Policy Risk